COMMUNIQUÉS West-GlobeNewswire

Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results and Corporate Update
01/05/2018
NOVATO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]
Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
01/05/2018
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Body Count: Canadians with curable illnesses are dying every day without pharmacare, according to a new study from Canada’s nurses
01/05/2018
OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses unveiled a new study today – the first of its kind in Canada – that reveals the number of people in Canada who die or fall ill because prescription medications [...]
Comptons les corps : Selon une nouvelle étude commandée par le personnel infirmier du Canada, des personnes atteintes de maladies curables meurent à chaque jour au pays en l’absence de régime universel d’assurance-médicaments
01/05/2018
OTTAWA, 01 mai 2018 (GLOBE NEWSWIRE) -- Le personnel infirmier du Canada a communiqué, aujourd’hui, une nouvelle étude – la première de ce genre au Canada – qui révèle le nombre de personnes au pays qui meurent ou [...]
Maple Leaf Begins Interior Construction on its Telkwa, British Columbia Facility
01/05/2018
CALGARY, Alberta, May 01, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO: MGW ) (OTCQB:MGWFF) is pleased to announce that it has received a progress report from the Company [...]
COCRYSTAL PHARMA, INC., PRICES $8,000,000 COMMON STOCK OFFERING
01/05/2018
TUCKER, GA and BOTHELL, WA, May 01, 2018 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) , (“Cocrystal” or the “Company”) a clinical stage biotechnology company focused on developing innovative antiviral [...]
Marrone Bio Innovations to Present at 3rd Annual RHK Capital Disruptive Growth & Healthcare Conference in New York on May 8th
01/05/2018
DAVIS, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
01/05/2018
VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSXV:APC) (FSE:0E8) is pleased to provide an update of progress during the third [...]
Golden Leaf Holdings Opens New Chalice Farms Dispensary in Happy Valley, Oregon
01/05/2018
PORTLAND, Ore., May 01, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility
01/05/2018
MELBOURNE, Australia, May 01, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq: GENE ) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic [...]
Trading by management and close relations of management
01/05/2018
Read the full announcement in the attached file Attachment 2018_21_Trading_by_management_EN
Shire plc : Rule 2.9 Announcement
01/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 May 2018 Shire [...]
Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Antimicrobial Agents and Chemotherapy
01/05/2018
Iclaprim met the primary endpoint Iclaprim was well tolerated in the study, with no nephrotoxicity observed Additional data from the previously announced results are included in the publication NEW YORK, May 01, 2018 ( [...]
DBV Technologies to Attend Upcoming Investor Conferences
01/05/2018
Montrouge, France, May 1, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs
01/05/2018
Montrouge, France, le 1 mai (7H30 CET), 2018 DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
AveXis Provides Update on Proposed Acquisition by Novartis AG
01/05/2018
CHICAGO, May 01, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
Novartis provides update on proposed acquisition of AveXis
01/05/2018
Basel, May 1 , 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") applicable to Novartis' cash [...]
Medibio Launches Global Corporate Mental Health Product
01/05/2018
Release of first commercially available mental health technology product Notable existing support from key Australian companies Provide organizations with cost savings by reducing mental health burden SYDNEY, Australia [...]
Lexington Releases Audited Consolidated Financial Statements
01/05/2018
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has released its audited [...]

Pages